Life sciences · Interventional Study
ClinicalTrials.gov · October 7, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07400042). This is a study registration, not published results. Lead sponsor: Wake Forest University Health Sciences. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 600 participants (ESTIMATED). Conditions: Congestive Heart Failure. Interventions: OTHER: peripheral venous pressure measurements; OTHER: standard clinical care. Primary outcome measures: Length of hospital stay , up to day 8; Number of subjects rehospitalized , Day 30 post index hospitalization; Number of subjects rehospitalized , Month 6 post index hospitalization. Brief summary: The purpose of the study is to determine if there is a reduction in the length of stay and rates of rehospitalization for patients diagnosed with congestive heart failure when physicians are provided daily measurements of peripheral venous pressure versus no daily measurements of peripheral venous pressure.